ASTROCYTOMA, GRADE III
Clinical trials for ASTROCYTOMA, GRADE III explained in plain language.
Never miss a new study
Get alerted when new ASTROCYTOMA, GRADE III trials appear
Sign up with your email to follow new studies for ASTROCYTOMA, GRADE III, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough brain cancers: early trial tests novel drug combo
Disease control CompletedThis early-stage study tested a new oral drug called TG02 for treating aggressive brain tumors (anaplastic astrocytoma and glioblastoma). It was given to elderly patients with newly diagnosed tumors alongside standard radiotherapy or chemotherapy, and to adults whose cancer had r…
Matched conditions: ASTROCYTOMA, GRADE III
Phase: PHASE1 • Sponsor: European Organisation for Research and Treatment of Cancer - EORTC • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
Experimental device tested to control aggressive brain tumor growth
Disease control CompletedThis study tested a medical device called NOVOTTF-200A in adults with a recurrent, aggressive type of brain tumor called grade 3 astrocytoma. The main goal was to see if the device could help control the tumor's growth for at least six months in patients who had not received a sp…
Matched conditions: ASTROCYTOMA, GRADE III
Phase: NA • Sponsor: Daniela A. Bota • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC